Trial Profile
A phase I trial evaluating the efficacy and safety of prasugrel in patients with sickle cell disease and healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2016
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Sickle cell anaemia
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 22 Mar 2016 New trial record